Cargando…
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries
In France, the incidence of invasive meningococcal disease (IMD) is around 1/100,000, with the following trends over the 2011–2018 period: a leading role of group B in subjects <15 years, a decrease of group C among <1 year since 2017, an increase of group W in all age groups including subject...
Autores principales: | Taha, Muhamed-Kheir, Gaudelus, Joël, Deghmane, Ala-Eddine, Caron, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644201/ https://www.ncbi.nlm.nih.gov/pubmed/32209010 http://dx.doi.org/10.1080/21645515.2020.1729030 |
Ejemplares similares
-
Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
por: Taha, Muhamed-Kheir, et al.
Publicado: (2020) -
Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022) -
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
por: Taha, Samy, et al.
Publicado: (2022) -
Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis
por: Deghmane, Ala-Eddine, et al.
Publicado: (2023) -
Late Repression of NF-κB Activity by Invasive but Not Non-Invasive Meningococcal Isolates Is Required to Display Apoptosis of Epithelial Cells
por: Deghmane, Ala-Eddine, et al.
Publicado: (2011)